CM
CM Management Portfolio holdings
AUM
$110M
This Quarter Return
+16.26%
1 Year Return
+9.76%
3 Year Return
+99.54%
5 Year Return
–
10 Year Return
–
AUM
$135M
AUM Growth
+$135M
(+25%)
Cap. Flow
+$7.99M
Cap. Flow
% of AUM
5.94%
Top 10 Holdings %
Top 10 Hldgs %
35.95%
Holding
101
New
21
Increased
28
Reduced
9
Closed
20
Top Buys
| 1 |
Amicus Therapeutics
FOLD
|
$3.56M |
| 2 |
Alico
ALCO
|
$2.24M |
| 3 |
Exelixis
EXEL
|
$1.81M |
| 4 |
Elicio Therapeutics
ELTX
|
$1.69M |
| 5 |
National Healthcare
NHC
|
$1.56M |
Top Sells
| 1 |
Aterian
ATER
|
$7.23M |
| 2 |
Aviat Networks
AVNW
|
$3.95M |
| 3 |
VYNE Therapeutics
VYNE
|
$3.43M |
| 4 |
ClearPoint Neuro
CLPT
|
$3.34M |
| 5 |
Intel
INTC
|
$2.49M |
Sector Composition
| 1 | Healthcare | 40.52% |
| 2 | Financials | 13.92% |
| 3 | Technology | 12.04% |
| 4 | Energy | 10.02% |
| 5 | Materials | 6.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Cytokinetics
CYTK
$4.23B
| $7.56M | 5.62% | 325,000 | – | – |
|
2
DURECT Corp
DRRX
$59.6M
| $5.27M | 3.92% | 2,650,000 | – | – |
|
|
CLDR
3
DELISTED
Cloudera, Inc.
CLDR
| $5.17M | 3.84% | 425,000 +25,000 | +6% | +$304K |
|
|
4
Alico
ALCO
$259M
| $4.93M | 3.66% | 165,000 +75,000 | +83% | +$2.24M |
|
|
TGB
5
Taseko Mines
TGB
$1.03B
| $4.56M | 3.39% | 2,650,000 | – | – |
|
|
6
Amicus Therapeutics
FOLD
$2.34B
| $4.45M | 3.3% | 450,000 +360,000 | +400% | +$3.56M |
|
|
RNWK
7
DELISTED
RealNetworks Inc
RNWK
| $4.36M | 3.24% | 1,025,000 -325,000 | -24% | -$1.38M |
|
8
Newmark Group
NMRK
$3.22B
| $4.25M | 3.16% | 425,000 +25,000 | +6% | +$250K |
|
9
inTEST
INTT
$87.3M
| $4.07M | 3.03% | 345,000 -55,200 | -14% | -$652K |
|
|
SFE
10
DELISTED
Safeguard Scientifics, Inc.
SFE
| $3.75M | 2.79% | 550,000 +50,000 | +10% | +$341K |
|
|
IMGN
11
DELISTED
Immunogen Inc
IMGN
| $3.04M | 2.26% | 375,000 | – | – |
|
12
Talos Energy
TALO
$1.73B
| $2.71M | 2.01% | 225,000 | – | – |
|
13
Republic Bancorp
RBCAA
$1.5B
| $2.44M | 1.81% | 55,000 +10,795 | +24% | +$478K |
|
14
BGC Group
BGC
$4.65B
| $2.42M | 1.79% | 500,000 +25,000 | +5% | +$121K |
|
15
Ark Restaurants
ARKR
$24.6M
| $2.32M | 1.72% | 115,000 | – | – |
|
16
Radiant Logistics
RLGT
$305M
| $1.91M | 1.42% | 275,000 | – | – |
|
|
CADE
17
DELISTED
Cadence Bancorporation
CADE
| $1.87M | 1.39% | 90,000 | – | – |
|
18
Merck
MRK
$210B
| $1.85M | 1.37% | 24,000 +19,000 | +380% | +$1.46M |
|
19
Pfizer
PFE
$141B
| $1.81M | 1.35% | 50,000 +40,000 | +400% | +$1.45M |
|
20
Cartesian Therapeutics
RNAC
$261M
| $1.81M | 1.35% | 400,000 +75,000 | +23% | +$339K |
|
|
21
Exelixis
EXEL
$10.1B
| $1.81M | 1.34% | +80,000 | New | +$1.81M |
|
22
OneSpan
OSPN
$580M
| $1.72M | 1.27% | 70,000 +40,000 | +133% | +$980K |
|
23
Rigel Pharmaceuticals
RIGL
$697M
| $1.71M | 1.27% | 500,000 +100,000 | +25% | +$342K |
|
|
24
Elicio Therapeutics
ELTX
$172M
| $1.69M | 1.26% | +93,750 | New | +$1.69M |
|
25
Viatris
VTRS
$12.3B
| $1.68M | 1.25% | 120,000 +88,139 | +277% | +$1.23M |
|